ACE2 and COVID-19: Various studies have investigated the influence of naturally occurring single nucleotide polymorphisms (SNPs) on infection variable susceptibility and severity through its effect on binding affinity to the viral S protein targeting ACE2 for COVID-19 therapy [6, 7].